Baird downgraded Nvidia from outperform to neutral, citing negative catalysts such as delayed data center forecasts and uncertainties surrounding CEO Jensen Huang's tenure. This reflects concerns about both supply chain issues and potential demand softening.
In contrast, UBS maintained a neutral stance on Apple, noting that iPhone wait times are decreasing, which could signal improved supply and demand dynamics. Goldman Sachs reiterated a buy rating on CoreWeave, emphasizing its technology differentiation and favorable contract economics, suggesting strong potential for equity returns.
Piper Sandler upgraded Alpha Tau Medical to overweight, highlighting its unique local alpha-radiation platform for treating solid tumors. Meanwhile, JPMorgan upgraded Republic Services, anticipating solid waste volume growth, and Mercury Systems, citing effective management and potential for value creation.
Jefferies initiated buy ratings on several companies, including Teradyne, Corning, and Zebra Technologies, indicating confidence in their growth prospects amid current market conditions. Overall, these analyst calls reflect a cautious yet opportunistic approach to investing in technology and healthcare sectors